Cargando…
RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment
Radiation therapy is a staple approach for cancer treatment, whereas radioresistance of cancer cells remains a substantial clinical problem. In response to ionizing radiation (IR) induced DNA-damage, cancer cells can sustain/activate pro-survival signaling pathways, leading to apoptotic resistance a...
Autores principales: | Hein, Ashley L., Post, Carl M., Sheinin, Yuri M., Lakshmanan, Imayavaramban, Natarajan, Amarnath, Enke, Charles A., Batra, Surinder K., Ouellette, Michel M., Yan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112160/ https://www.ncbi.nlm.nih.gov/pubmed/27181206 http://dx.doi.org/10.1038/onc.2016.163 |
Ejemplares similares
-
Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
por: Yan, Ying, et al.
Publicado: (2014) -
Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
por: Yan, Ying, et al.
Publicado: (2020) -
Rac1 GTPase in pancreatic cancer
por: Yan, Ying, et al.
Publicado: (2015) -
hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells
por: Karmakar, Saswati, et al.
Publicado: (2017) -
Discovery and characterization of small molecule Rac1 inhibitors
por: Arnst, Jamie L., et al.
Publicado: (2017)